Brad Baker, MD
Retina Specialist · Worcester, MANPI 1508853821
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (56.4%), food and beverage and education — rather than concentrated in one kind of arrangement. Janssen Research & Development, LLC accounts for 67.8% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2022 at $1,684 and has fallen 87.7% since, to $207 in 2025.
Across 33 payments — averaging $74.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Research & Development, LLC$2K
- Novartis$204
- Genentech USA, Inc.$182
- Alcon$154
- Regeneron Healthcare Solutions, Inc.$112
- Astellas Pharma US Inc$48
- plus $88 from 4 others
Across 15 payments — averaging $1934.66 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$28K
- Regeneron$1K
What the payments were for
- Travel & lodging$1,38456%
- Food & beverage$1,05143%
- Education$171%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Research & Development, LLC | 9 | $1,663 |
| Novartis | 4 | $204 |
| Genentech USA, Inc. | 7 | $182 |
| Alcon | 1 | $154 |
| Regeneron Healthcare Solutions, Inc. | 5 | $112 |
| Astellas Pharma US Inc | 2 | $48 |
| Apellis Pharmaceuticals, Inc. | 2 | $36 |
| AbbVie | 1 | $21 |
| Harrow Eye, LLC | 1 | $19 |
| Alimera Sciences, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Constellation$154
- BEOVU$106
How this compares
$2,452 in reported general payments places this provider in the 70th percentile of 26 retina specialist providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 50 | $3,184 |
| Brimonidine Tartrate | 18 | $2,896 |
| Ketorolac Tromethamine | 20 | $598 |
| Ofloxacin | 16 | $195 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 13 | $178 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Worcester
- Bryan HongWorcester$1K
- Frank McCabeWorcester$1K
- Mark BarsamianWorcester$378
- Melvyn DefrinWorcester$21
- Jeffrey HeierBoston$1.5M
- Alyse RichardDartmouth$37K
- Andre WitkinBoston$23K
- Chirag ShahBoston$14K
- Elite Bor-ShavitLancaster$11K
- Rebecca SoaresSpringfield$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.